Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

TRAINABLE DATA ASSETS

in Corporate Electronic Memory

(IP Asset Classes I, II, III, V, X)

11 of 52 existing pages

 

IP Asset Class I: +6,200 Scientific articles

• Journal PharmaceuticalIntelligence.com

IP Asset Class II: 48 e-Books in Medicine

• BioMed e-Series
• Audio English-Spanish: BioMed e-Series
• Five Bilingual BioMed e-Series
• Press Releases

IP Asset Class III: e-Proceedings and Tweet Collections

• Press Coverage

IP Asset Class V: Media Gallery

• Media Gallery accessed via Editor’s Dashboard
• >7,500 Biological Images. See COM, Part 6

IP Asset Class X: Library of Podcasts

• e-VOICES Podcasting
• BioMed Audio Podcast Library @LPBI Group

 

Other TRAINABLE Data Assets

• Coronavirus, SARS-CoV-2 Portal
• Artificial Intelligence: Genomics & Cancer
• Cell Therapy in Regenerative Medicine, 2026 and Beyond
• Medical 3D Printing

 

e-Reputation and INTANGIBLES

in Corporate Strategic MEMORY

24 of 52 Existing Pages

• LPBI Group’s History
• 1.0 LPBI – 2012-2020 VISTA
• 2.0 LPBI – 2021-2025 VISION
• Founder’s Vision
• Founder’s Bio
• Intangibles CIM
• Our TEAM
• LPBI India
• Knowledge PORTALS System (KPS)

Drug Discovery Efforts

• DrugDiscovery @LPBI Group
• Synthetic Biology in Drug Discovery – AI Development

  

EDUCATION and Pilot AI Studies Initiatives

with 3rd Parties

• 2021 Summer Internship Portal
• 2021-2025 Medical Text Analysis (NLP)
• Certificate One Year
• Medical School Education: Use of LPBI Group’s Contents

Legacy and Organization’s Memory

• Funding, Deals & Partnerships
• 2.0 LPBI Executive Summary
• 2.0 LPBI Brochure
• 1.0 LPBI Executive Summary
• 1.0 LPBI Brochure
• 1.0 LPBI Group News
• 1.0 LPBI CALENDAR
• LPBI Newsletters
• Customer Surveys

• Composition of Methods (COM) – IP Asset Class IV: Part 1 to Part 9 – Tool Factory for Health AI Analytics

• In 2026, COM consists of the following 14 Parts, of which

• Part 1 to Part 9 were developed pre-2026

Part 1: The “Curation Methodology” of Scientific Findings

Part 2: SOP on IT aspects of Data Management on the Website [exits as a Page]

Part 3: Exploratory Protocols for Multimodal Foundation Model in Healthcare

Part 4: Valuation Model for TEN IP Asset Classes

Part 5: Process workflows for six IP Asset Classes

Part 6: Media Gallery of >7,500 Biological Images

Part 7: Royalties – Data collection on Amazon.com KDP

Part 8: IP Asset Class III: Aggregate Calculations of Views for e-Proceedings and Tweet Collections

Part 9: Scoop.it Platform: Aviva Launched Three Journals since 2013 – a mini vault of N = 888 article titles on Cardiovascular Evidence-based Medicine

•  Parts 10 to 14, were developed in 2026

Part 10: Multimodal Methods of Execution Infrastructure (EI) for AI Data Analyses and Exposition of the Analyses Results

Part 11 – Validation Models for Execution Infrastructures – Library of Modules: Module 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19

Part 12 – Monetization Schedules for the Hybrid Model, Human & AI – Library of Systems: System 1, System 2, System 3, System 4

Part 13 –Training Data Sets for 15 SMALL Language Models: List of Articles in each Data Set and Methods for Content Augmentation for Transitioning SML to LLM

Part 14 – 24/7 Autonomous Journal Article Updating System (AJAUS): Integrated Architecture (AJAUS + NemoClaw)

 

AI Asset Development & Management  

• Multimodal Healthcare Foundation Model– AI Development
• Blockchain Transactions Network Ecosystem
• NFT: Redefined Format of IP Assets
• AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
• Medicine with GPT-4 & ChatGPT
• ChatGPT + Wolfram PlugIn

 

Venture Management 

• Testimonials about LPBI
• 2.0 LPBI Group News
• 2.0 LPBI – Calendar of Zooms – 2026 Monthly Board Meetings
• Portfolio of IP Assets
• Investor Relations
• Health Care INVESTOR’s Corner ($)
• SOP Web STAT– Web Site Data Management – Part 6 in COM
• Contact Us